INTERFERON BETA 1B FOR THE IMMUNOMODULATORY TREATMENT OF MULTIOCULAR SCLEROSIS IN PEDIATRIC NEUROLOGIC PRACTICES

Medications for the immunomodulatory therapy of the multiocular sclerosis are widely spread and have been applied in adult neurologic practices for a long time, although the data about their use among the patients under 18 is scarce and not classified. We present the history of foreign and russian e...

Full description

Saved in:
Bibliographic Details
Published inPediatricheskai͡a︡ farmakologii͡a︡ : nauchno-prakticheskiĭ zhurnal Soi͡u︡za pediatrov Rossii Vol. 3; no. 6; pp. 35 - 38
Main Authors O.V. Bykova, L.M. Kuzenkova, L.M. Vysotskaya, O.I. Maslova, A.N. Boiko
Format Journal Article
LanguageRussian
Published Union of pediatricians of Russia 01.12.2006
Online AccessGet full text

Cover

More Information
Summary:Medications for the immunomodulatory therapy of the multiocular sclerosis are widely spread and have been applied in adult neurologic practices for a long time, although the data about their use among the patients under 18 is scarce and not classified. We present the history of foreign and russian experience in application of the medication for the immunomodulatory therapy of the multiocular sclerosis — interferon beta 1b — among children and teenagers along with the brief analysis of the acquired data about effectiveness and safety of this type of treatment in pediatrics in the published research.Key words: multiocular sclerosis, immunomodulatory therapy, children, teenagers.
ISSN:1727-5776
2500-3089